These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 16899194)

  • 21. ABO incompatibility--when is antenatal testing indicated?
    Beischer NA
    Aust N Z J Obstet Gynaecol; 1997 Aug; 37(3):315. PubMed ID: 9325514
    [No Abstract]   [Full Text] [Related]  

  • 22. Polymerase-chain-reaction-based detection of fetal rhesus D and Y-chromosome-specific DNA in the whole blood of pregnant women during different trimesters of pregnancy.
    Al-Yatama MK; Mustafa AS; Al-Kandari FM; Khaja N; Zohra K; Monem RA; Abraham S
    Med Princ Pract; 2007; 16(5):327-32. PubMed ID: 17709918
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk free simultaneous prenatal identification of fetal Rhesus D status and sex by multiplex real-time PCR using cell free fetal DNA in maternal plasma.
    Zhong XY; Holzgreve W; Hahn S
    Swiss Med Wkly; 2001 Feb; 131(5-6):70-4. PubMed ID: 11383228
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Rhesus conflict during pregnancy].
    Sergienko NS
    Feldsher Akush; 1988 Mar; 53(3):28-32. PubMed ID: 3132402
    [No Abstract]   [Full Text] [Related]  

  • 25. The use of maternal plasma for prenatal RhD blood group genotyping.
    Finning K; Martin P; Daniels G
    Methods Mol Biol; 2009; 496():143-57. PubMed ID: 18839110
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical applications of cell-free fetal DNA from maternal plasma.
    Rijnders RJ; Christiaens GC; Bossers B; van der Smagt JJ; van der Schoot CE; de Haas M
    Obstet Gynecol; 2004 Jan; 103(1):157-64. PubMed ID: 14704260
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prenatal determination of fetal blood group status.
    Avent ND; Finning KM; Martin PG; Soothill PW
    Vox Sang; 2000; 78 Suppl 2():155-62. PubMed ID: 10938946
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prenatal diagnosis of the Rhesus D fetal blood type on amniotic fluid in daily practice.
    Goebel JC; Soergel P; Pruggmayer M; Mühlhaus K; Stuhrmann M; Scharf A
    Arch Gynecol Obstet; 2008 Feb; 277(2):155-60. PubMed ID: 17701192
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Antenatal determination of fetal RhD-blood type based on fetal DNA in plasma from the RhD-negative mother--secondary publication].
    Clausen FB; Krog GR; Rieneck K; Nielsen LK; Lundquist R; Finning K; Dickmeiss E; Hedegaard M; Dziegiel MH
    Ugeskr Laeger; 2006 Jun; 168(26-32):2568-70. PubMed ID: 16824414
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-invasive antenatal diagnosis.
    Gaudoin MR
    Lancet; 1993 Jul; 342(8862):54-5. PubMed ID: 8100327
    [No Abstract]   [Full Text] [Related]  

  • 31. The prevalence of Rhesus negativity among pregnant women in Enugu, Southeast Nigeria.
    Okeke TC; Ocheni S; Nwagha UI; Ibegbulam OG
    Niger J Clin Pract; 2012; 15(4):400-2. PubMed ID: 23238187
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic accuracy of noninvasive fetal Rh genotyping from maternal blood--a meta-analysis.
    Geifman-Holtzman O; Grotegut CA; Gaughan JP
    Am J Obstet Gynecol; 2006 Oct; 195(4):1163-73. PubMed ID: 17000250
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fetal RhD genotyping: a more efficient use of anti-D immunoglobulin.
    Daniels G; Finning K; Martin P; Summers J
    Transfus Clin Biol; 2007 Dec; 14(6):568-71. PubMed ID: 18436463
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PCR-based determination of Rhc and RhE status of fetuses at risk of Rhc and RhE haemolytic disease.
    Le Van Kim C; Mouro I; Brossard Y; Chavinié J; Cartron JP; Colin Y
    Br J Haematol; 1994 Sep; 88(1):193-5. PubMed ID: 7803243
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prenatal typing of fetal DNA in cases of potential alloimmune haemolytic disease of the newborn: clinical benefit outweighs disadvantage.
    Shields JA
    Br J Biomed Sci; 1999; 56(1):49-55. PubMed ID: 10492915
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blocked D phenomenon.
    Lee E
    Blood Transfus; 2013 Jan; 11(1):10-1. PubMed ID: 22790264
    [No Abstract]   [Full Text] [Related]  

  • 37. Use of maternal plasma for noninvasive determination of fetal RhD status.
    Harper TC; Finning KM; Martin P; Moise KJ
    Am J Obstet Gynecol; 2004 Nov; 191(5):1730-2. PubMed ID: 15547554
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recent advances in non-invasive prenatal DNA diagnosis through analysis of maternal blood.
    Sekizawa A; Purwosunu Y; Matsuoka R; Koide K; Okazaki S; Farina A; Saito H; Okai T
    J Obstet Gynaecol Res; 2007 Dec; 33(6):747-64. PubMed ID: 18001438
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Noninvasive fetal RHD genotyping in the first trimester of pregnancy.
    Cardo L; Prieto B; Alvarez FV
    Prenat Diagn; 2012 Jan; 32(1):99. PubMed ID: 22367674
    [No Abstract]   [Full Text] [Related]  

  • 40. [Prenatal diagnosis and current status of the prevention of feto-maternal isoimmunization by anti-D].
    Martín Vega C
    Sangre (Barc); 1997 Jun; 42(3):239-41. PubMed ID: 9381270
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.